SCHEMBL8523235

SCHEMBL8523235

C1=CC=C2C=NC=CN2C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2994409 0.69
SCHEMBL6088958 0.68
SCHEMBL6088949 0.68
SCHEMBL23330241 0.68
SCHEMBL942850 0.67
SCHEMBL2360883 0.67
Hydrochloric Acid SCHEMBL30153676 0.55
SCHEMBL17232939 0.53
SCHEMBL105522 0.53
SCHEMBL23330239 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022162265-A1 ANTIMICROBIALS AGAINST PATHOGENS OF THE GENUS STREPTOCOCCUS CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) 2022-08-04 WO disclosed
US-20210154188-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. 2021-05-27 US disclosed
WO-1999020279-A1 POTENTIATION OF PHARMACEUTICALS ELI LILLY AND COMPANY (US) 1999-04-29 WO disclosed
EP-0126343-A1 Treatment of diarrhoea BEECHAM GROUP PLC (GB) 1984-11-28 EP disclosed